Cancer Immunology and Immunotherapy: Volume 1 of Delivery Strategies and Engineering Technologies in Cancer...

— —

Mansoor Amiji (Distinguished Professor and Chairman, Department of Pharmaceutical Sciences, School of Pharmacy, Bouve College of Health Sciences, Northeastern University, Boston, Massachusetts, USA) Lara Milane (Assistant Teaching Professor in Biotechnology, Bouve College of Health Sciences, Northeastern University, USA)

Cancer Immunology and Immunotherapy

Volume 1 of Delivery Strategies and Engineering Technologies in Cancer Immunotherapy

Mansoor Amiji (Distinguished Professor and Chairman, Department of Pharmaceutical Sciences, School of Pharmacy, Bouve College of Health Sciences, Northeastern University, Boston, Massachusetts, USA), Lara Milane (Assistant Teaching Professor in Biotechnology, Bouve College of Health Sciences, Northeastern University, USA)

$378.95

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Academic Press Inc
27 August 2021

Pharmaceutical industries; Epidemiology & medical statistics; Immunology; Pharmacology; Biotechnology

Delivery Technologies for Immuno-Oncology: Volume 1: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy examines the challenges of delivering immuno-oncology therapies. Immuno-oncology (IO) is a growing field of medicine at the interface of immunology and cancer biology leading to development of novel therapeutic approaches, such as chimeric antigen receptor T-cell (CAR-T) and immune checkpoint blockade antibodies, that are clinically approved approaches for cancer therapy. Although currently approved IO approaches have shown tremendous promise for select types of cancers, broad application of IO strategies could even further improve the clinical success, especially for diseases such as pancreatic cancer, brain tumors where the success of IO so far has been limited.

Nanotechnology-based targeted delivery strategies could improve the delivery efficiency of IO agents as well as provide additional avenues for novel therapeutic and vaccination strategies. Additionally, a number of locally-administered immunogenic scaffolds and therapeutic strategies, such as the use of STING agonist, could benefit from rationally designed biomaterials and delivery approaches.

Delivery Technologies for Immuno-Oncology: Volume 1: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy creates a comprehensive treaty that engages the scientific and medical community who are involved in the challenges of immunology, cancer biology, and therapeutics with possible solutions from the nanotechnology and drug delivery side.

Edited by: Mansoor Amiji (Distinguished Professor and Chairman Department of Pharmaceutical Sciences School of Pharmacy Bouve College of Health Sciences Northeastern University Boston Massachusetts USA), Lara Milane (Assistant Teaching Professor in Biotechnology, Bouve College of Health Sciences, Northeastern University, USA)
Imprint: Academic Press Inc
Country of Publication: United States
Dimensions: Height: 235mm, Width: 191mm,
Weight: 1.130kg
ISBN: 9780128233979
ISBN 10: 0128233974
Pages: 548
Publication Date: 27 August 2021
Audience: Professional and scholarly , Undergraduate
Format: Paperback
Publisher's Status: Active

1. The hallmarks of cancer and immunology 2. Innate and adaptive immunity in cancer 3. Inflammation and cancer 4. Novel immunotherapeutic approaches to cancer: Voltage-gated sodium channel expression in immune cells and tumors 5. Immunoediting and cancer priming 6. Metabolic reprogramming and immunity in cancer 7. Epigenetic programming of the immune responses in cancer 8. Cellular therapeutics in immuno-oncology 9. T-cell engaging bispecific antibody therapy 10. Role of microbiome in cancer immunotherapy 11. STING pathway and modulation for cancer immunotherapy 12. Oncolytic viruses in immunotherapy 13. Comparison of therapeutic strategies for immuno-oncology 14. Intrinsic and acquired cancer immunotherapy resistance 15. Preclinical and clinical toxicity of immuno-oncology agents and mitigation strategies

Mansoor M. Amiji is the Distinguished Professor and Chairman of the Department of Pharmaceutical Sciences at the Bouve College of Health Sciences at Northeastern University. Dr. Amiji has edited a number of books and is a frequently published author. His research focuses on the synthesis of novel polymeric materials for medical and pharmaceutical applications, drug delivery systems and nanomedical technologies, and his contributions in research advising, grant reviews for various organizations and editorial work for journals are invaluable. Dr. Lara Milane is Assistant Teaching Professor in Biotechnology at the Bouve College of Health Sciences at Northeastern University. She is interested in Mitochondrial Medicine. She is working on developing nanomedicines for a range of diseases (cancer, neurodegenerative disease, aging) that manipulate mitochondria for therapeutic outcomes. Dr. Milane was trained as a National Cancer Institute/ National Science Foundation Nanomedicine Fellow at Northeastern University, Boston, MA. Dr. Milane is an intuitive cancer biologist with research interests in developing translational nanomedicines that exploit the hallmarks of cancer.?